Background
Larry Junker invented a new handle design for a peelable introducer sheath — a medical device used in catheter procedures. He filed a design patent application on February 7, 2000, which ultimately issued as Design Patent No. D450,839. Years before filing, Junker had partnered with James Eddings, whose manufacturing company created prototypes of the device.
In January 1999 — more than one year before Junker’s filing date — Eddings sent a detailed letter to Boston Scientific Corporation in response to their request for a quotation. The letter included a price-and-quantity grid listing various sizes of the peelable introducer sheath products, along with delivery terms (bulk, non-sterile), shipment terms (FOB Athens, Texas), and payment terms (net 30 days). The critical date for the on-sale bar was February 7, 1999.
Junker sued Medical Components, Inc. and Martech Medical Products for infringing the design patent. The district court granted summary judgment to Junker, finding that the letter was merely a preliminary quotation rather than a binding commercial offer. Medical Components appealed, arguing the letter triggered the on-sale bar and invalidated the patent.
The Court’s Holding
The Federal Circuit reversed the district court. Applying traditional contract law principles drawn from the Uniform Commercial Code and the Restatement (Second) of Contracts, the court concluded that the letter constituted a “commercial offer for sale” rather than preliminary negotiations. The court emphasized that the letter must be evaluated in its entirety and in the context of the surrounding circumstances.
The letter contained all the hallmarks of a commercial offer: definite pricing organized in a quantity-discount grid, specific delivery and shipment terms, payment conditions, and the identity of the goods offered. Boston Scientific could have accepted the letter and bound the parties to a contract without further negotiation. The fact that the letter used the word “quotation” was not dispositive — the substance of the communication controlled over its label.
Because the on-sale bar applies equally to design patents, utility patents, and plant patents, the court held the design patent invalid under pre-AIA 35 U.S.C. § 102(b). The court rejected the argument that the design was still in development and therefore not “ready for patenting,” noting the prototype had been manufactured and the pricing fully specified.
Key Takeaways
- The on-sale bar applies to design patents with the same force as utility patents — a commercial offer for sale of a patented design more than one year before the application filing date invalidates the patent.
- Courts evaluate whether a communication constitutes a “commercial offer for sale” based on its substance: the presence of specific price, quantity, delivery, and payment terms that would allow acceptance to form a binding contract weighs strongly toward finding an offer.
- Labeling a communication a “quotation” or “preliminary inquiry” does not insulate it from constituting a commercial offer if the content reflects complete contractual terms.
- Inventors who engage manufacturing partners or potential customers before filing must be careful to avoid communications that specify product, pricing, and delivery terms — these can trigger the on-sale bar even if a deal was never consummated.
Why It Matters
This decision is a cautionary tale for inventors — especially in the medical device and industrial design space — about the risks of engaging commercial partners before securing patent protection. The on-sale bar is a strict rule: if the patented design was the subject of a commercial offer for sale more than a year before filing, the patent is invalid, full stop. The fact that Junker’s partner was helping to develop the product and merely responding to a customer’s inquiry did not protect him.
The broader lesson is that prototype-stage communications must be carefully structured. Inventors and their business partners should avoid providing specific pricing, delivery, and payment terms to potential buyers until a patent application has been filed. What looks like routine sales activity — responding to a request for a price quote — can silently start the one-year clock ticking on the on-sale bar.